- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
RINVOQ - 15mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA44 | B | Upadacitinib - 15mg | 10374 | 45520/1 | RINVOQ | 15mg | 30 | Tablet, prolonged release | Oral | Interpharma S.A.L. | Abbvie Ireland NL BV | Ireland | 45,469,094 L.L | 10.71 | E1 | Abbvie Deutschland GmbH & Co KG | Germany | 2/5/2024 | 0 |